|1.||Shimizu, Kuniyoshi: 1 article (07/2007)|
|2.||Kondo, Ryuichiro: 1 article (07/2007)|
|3.||Konishi, Fumiko: 1 article (07/2007)|
|4.||Kumamoto, Shoichiro: 1 article (07/2007)|
|5.||Liu, Jie: 1 article (07/2007)|
|1.||Prostatic Neoplasms (Prostate Cancer)
07/15/2007 - "In conclusion, our result suggests that ganoderol B might be useful in prostate cancer and benign prostatic hyperplasia (BPH) therapy through suppressing the function of androgen and its receptor."
07/15/2007 - "In view of the fact that PSA (prostatic specific antigen, a well-accepted prognostic indicator of prostate cancer) is down-regulated, an important implication of this study is that ganoderol B intervention strategy aimed at toning down the amplitude of androgen signaling could be helpful in controlling morbidity of prostate cancer. "
|2.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)